spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online May 21, 2007
doi: 10.1242/10.1242/jcs.03450

Journal of Cell Science 120, 1833-1840 (2007)
Published by The Company of Biologists 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Negrini, M.
Right arrow Articles by Croce, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Negrini, M.
Right arrow Articles by Croce, C. M.

Commentary

MicroRNAs in human cancer: from research to therapy

Massimo Negrini1,*, Manuela Ferracin1, Silvia Sabbioni1 and Carlo M. Croce1,2

1 Dipartimento di Medicina Sperimentale e Diagnostica, Centro Interdipartimentale per la Ricerca sul Cancro, Università di Ferrara, via Luigi Borsari 46, 44100 Ferrara, Italy
2 Comprehensive Cancer Center, Ohio State University, Columbus OH 43210, USA

* Author for correspondence (e-mail: ngm{at}unife.it)

Accepted 2 April 2007

Numerous miRNAs are deregulated in human cancers, and experimental evidence indicates that they can play roles as oncogenes or tumor suppressor genes. Similarly to cancer genes that encode proteins, deregulation of miRNA-encoding genes is associated with genetic or epigenetic alterations, such as deletions, amplifications, point mutations and aberrant DNA methylation. The discovery that miRNAs interact with known oncogenes has established further links with molecular pathways implicated in malignant transformation. Finally, miRNAs can be used as diagnostic markers, and their potential as therapeutic molecules has moved miRNAs from the area of basic research to the field of cancer biotechnology.

Key words: microRNA, Cancer, Microarray, Oncogenes, Tumor suppressor genes




This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
M. N. Nikiforova, G. C. Tseng, D. Steward, D. Diorio, and Y. E. Nikiforov
MicroRNA Expression Profiling of Thyroid Tumors: Biological Significance and Diagnostic Utility
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1600 - 1608.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Yang, W. Kong, L. He, J.-J. Zhao, J. D. O'Donnell, J. Wang, R. M. Wenham, D. Coppola, P. A. Kruk, S. V. Nicosia, et al.
MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN
Cancer Res., January 15, 2008; 68(2): 425 - 433.
[Abstract] [Full Text] [PDF]


© The Company of Biologists Ltd 2007